Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.

Gregson, J; Kaleebu, P; Marconi, VC; van Vuuren, C; Ndembi, N; Hamers, RL; Kanki, P; Hoffmann, CJ; Lockman, S; Pillay, D; +9 more... de Oliveira, T; Clumeck, N; Hunt, G; Kerschberger, B; Shafer, RW; Yang, C; Raizes, E; Kantor, R; Gupta, RK; (2016) Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. The Lancet infectious diseases. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(16)30469-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(16)30469-8

Abstract

Share

Download

Filename: Occult HIV-1 drug resistance to_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar